rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
|
17785557 |
2007 |
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
|
17785557 |
2007 |
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.
|
17785557 |
2007 |
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.
|
25213701 |
2014 |
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.
|
25213701 |
2014 |
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.
|
25213701 |
2014 |
rs138983188
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Id4 was over-expressed in prostate cancer cell line DU145 harboring mutant p53 (P223L and V274F) and silenced in LNCaP cells with wild type p53.
|
24330748 |
2013 |
rs1057520005
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Id4 was over-expressed in prostate cancer cell line DU145 harboring mutant p53 (P223L and V274F) and silenced in LNCaP cells with wild type p53.
|
24330748 |
2013 |
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Our study provided evidence that the P53 intron 6 G>A and R72P G>C polymorphisms were associated with a higher risk of prostate cancer in a Northern Indian population.
|
21565625 |
2011 |
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Our study provided evidence that the P53 intron 6 G>A and R72P G>C polymorphisms were associated with a higher risk of prostate cancer in a Northern Indian population.
|
21565625 |
2011 |
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Our study provided evidence that the P53 intron 6 G>A and R72P G>C polymorphisms were associated with a higher risk of prostate cancer in a Northern Indian population.
|
21565625 |
2011 |
rs143458271
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our study provided evidence that the P53 intron 6 G>A and R72P G>C polymorphisms were associated with a higher risk of prostate cancer in a Northern Indian population.
|
21565625 |
2011 |
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
p53 Pro72Arg polymorphism and prostate cancer in men of African descent.
|
20593380 |
2010 |
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
p53 Pro72Arg polymorphism and prostate cancer in men of African descent.
|
20593380 |
2010 |
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
p53 Pro72Arg polymorphism and prostate cancer in men of African descent.
|
20593380 |
2010 |
rs138983188
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Silencing of CD24 enhanced restoration of PRIMA-1-induced mutant p53 in endogenous TP53(P223L/V274F) DU145 cells and in PC3 cells transfected with TP53(R273H) CONCLUSIONS: In human prostate cancers, there is CD24-dependent inactivation of mutant p53.
|
26712693 |
2016 |
rs1057520005
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Silencing of CD24 enhanced restoration of PRIMA-1-induced mutant p53 in endogenous TP53(P223L/V274F) DU145 cells and in PC3 cells transfected with TP53(R273H) CONCLUSIONS: In human prostate cancers, there is CD24-dependent inactivation of mutant p53.
|
26712693 |
2016 |
rs28934576
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Silencing of CD24 enhanced restoration of PRIMA-1-induced mutant p53 in endogenous TP53(P223L/V274F) DU145 cells and in PC3 cells transfected with TP53(R273H) CONCLUSIONS: In human prostate cancers, there is CD24-dependent inactivation of mutant p53.
|
26712693 |
2016 |
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
SNP309 T alleles were associated with a significantly decreased prostate cancer risk among Pro72Arg Pro </span>alleles carriers (OR=0.79, 95% CI, 0.64-0.98).
|
26025918 |
2016 |
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
SNP309 T alleles were associated with a significantly decreased prostate cancer risk among Pro72Arg Pro </span>alleles carriers (OR=0.79, 95% CI, 0.64-0.98).
|
26025918 |
2016 |
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
SNP309 T alleles were associated with a significantly decreased prostate cancer risk among Pro72Arg Pro </span>alleles carriers (OR=0.79, 95% CI, 0.64-0.98).
|
26025918 |
2016 |
rs138983188
|
|
|
0.030 |
GeneticVariation |
BEFREE |
These results provide first evidence to implicate the functional Pro64His variant of galectin-3 (LGALS3) in the genetic susceptibility towards prostate cancer.
|
21396839 |
2013 |
rs1042522
|
|
|
0.060 |
GeneticVariation |
BEFREE |
This study shows that the overall risk of prostate cancer was not associated with Arg72Pro SNP and HPV infection in our cohort.
|
21778786 |
2011 |
rs1131691014
|
|
|
0.060 |
GeneticVariation |
BEFREE |
This study shows that the overall risk of prostate cancer was not associated with Arg72Pro SNP and HPV infection in our cohort.
|
21778786 |
2011 |
rs878854066
|
|
|
0.060 |
GeneticVariation |
BEFREE |
This study shows that the overall risk of prostate cancer was not associated with Arg72Pro SNP and HPV infection in our cohort.
|
21778786 |
2011 |